A system for reviewing and monitoring cancer research protocols
Official title: Protocol Review and Monitoring System
Funded at University of Rochester · NIH-11014536 · Data updated 2026-11-12
This study is all about making sure that cancer research at the University of Rochester is safe and effective for patients like you, by having experts carefully review and approve the studies before they start.
Quick facts
| Grant type | P30 center grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Rochester NIH-funded |
| Lab location | 1 site (Rochester, United States) |
| Project start | March 15, 2025 |
| Project end | February 28, 2030 |
| Funding year | 2025 |
| Award (this year) | $75,939 |
| NIH project number | 1P30CA272302-01A1 |
| Project ID | NIH-11014536 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation are individuals diagnosed with cancer who are interested in contributing to clinical trials and research.
✕Less likely to help
Patients who are not diagnosed with cancer or are not eligible for clinical trials may not receive any benefit from this research.
What this research studies
The Protocol Review and Monitoring System (PRMS) at the Wilmot Cancer Institute ensures that all cancer studies involving human subjects at the University of Rochester are scientifically sound and well-designed. This system involves a two-stage review process where Disease Working Groups assess the feasibility and priority of studies, followed by an independent committee that decides which studies can proceed. Patients can benefit from this rigorous oversight as it aims to enhance the quality and effectiveness of cancer research. The PRMS also emphasizes community engagement and collaboration to ensure that research aligns with patient needs.
Why it matters
Potential benefit: If successful, this research could lead to more effective and scientifically validated cancer treatments for patients.
How similar studies have gone: Similar research approaches have shown success in improving the quality and outcomes of clinical trials in cancer treatment.
Where this research is happening
-
University of Rochester
Rochester, United States Active
Researchers
- Principal investigator: Linehan, David C — University of Rochester
- Study coordinator: Linehan, David C
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.